http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0196121-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19aba17957c7c206fc7209c181e0bdf1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
filingDate 1986-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7622ef6e2aec3591cdaece3b60e3ff83
publicationDate 1986-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0196121-A1
titleOfInvention Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
abstract The process for obtaining the preparation used in the treatment of a skin disease psoriasis, whereby to a mixture of the components usually used for the preparation of, so called, greasy vehicle, a solution of the active ingredients being 9-fluoro-11-17,21-trihydroxy-16-methyl pregna-1,4-diene-3,20-dion-17,21-dipropionate and/or 6,9-difluoro-11,16,17,21-tetrahydroxy-pregna-1,4-diene-3,20-21-acetate-16,17-acetonide is added.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9602254-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5707981-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE36606-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0266992-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0740930-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0740930-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0266992-A2
priorityDate 1985-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3934013-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2084465-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396889
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15070155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419890815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129262376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426636

Total number of triples: 50.